Related references
Note: Only part of the references are listed.AAVrh10 Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine Globoid Cell Leukodystrophy (Krabbe Disease)
Allison M. Bradbury et al.
HUMAN GENE THERAPY (2018)
Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy
Sarah Morar Schneider et al.
MOLECULAR IMAGING AND BIOLOGY (2018)
Systemic administration of the antisense oligonucleotide NS-065/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy
Hirofumi Komaki et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Gene editing restores dystrophin expression in a canine model of Duchenne muscular dystrophy
Leonela Amoasii et al.
SCIENCE (2018)
Considering aspects of the 3Rs principles within experimental animal biology
Lynne U. Sneddon et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2017)
Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy
Yusuke Echigoya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy (vol 8, 14454, 2017)
Niclas E. Bengtsson et al.
NATURE COMMUNICATIONS (2017)
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy
Caroline Le Guiner et al.
NATURE COMMUNICATIONS (2017)
The golden retriever model of Duchenne muscular dystrophy
Joe N. Kornegay
SKELETAL MUSCLE (2017)
CRISPR-Cpf1 correction of muscular dystrophy mutations in human cardiomyocytes and mice
Yu Zhang et al.
SCIENCE ADVANCES (2017)
Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy
Chengzu Long et al.
SCIENCE (2016)
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Mohammadsharif Tabebordbar et al.
SCIENCE (2016)
Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapies
T. C. Nichols et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration
Keiichiro Suzuki et al.
NATURE (2016)
Use of the six-minute walk test to characterize golden retriever muscular dystrophy
Austin R. Acosta et al.
NEUROMUSCULAR DISORDERS (2016)
Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs
Mary Beth Callan et al.
PLOS ONE (2016)
Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus
Yongping Yue et al.
HUMAN MOLECULAR GENETICS (2015)
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Catherine L. Bladen et al.
HUMAN MUTATION (2015)
Gene therapy for Duchenne muscular dystrophy
Julian Ramos et al.
EXPERT OPINION ON ORPHAN DRUGS (2015)
In Silico Screening Based on Predictive Algorithms as a Design Tool for Exon Skipping Oligonucleotides in Duchenne Muscular Dystrophy
Yusuke Echigoya et al.
PLOS ONE (2015)
Pharmacologic Management of Duchenne Muscular Dystrophy: Target Identification and Preclinical Trials
Joe N. Kornegay et al.
ILAR JOURNAL (2014)
Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy
Zheng Fan et al.
NEUROMUSCULAR DISORDERS (2014)
Skipping Multiple Exons of Dystrophin Transcripts Using Cocktail Antisense Oligonucleotides
Yusuke Echigoya et al.
NUCLEIC ACID THERAPEUTICS (2014)
Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients
David G. Ousterout et al.
MOLECULAR THERAPY (2013)
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
Joe N. Kornegay et al.
MAMMALIAN GENOME (2012)
A call for transparent reporting to optimize the predictive value of preclinical research
Story C. Landis et al.
NATURE (2012)
Bodywide skipping of exons 45-55 in dystrophic mdx52 mice by systemic antisense delivery
Yoshitsugu Aoki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Gene therapy rescues photoreceptor blindness in dogs and paves the way for treating human X-linked retinitis pigmentosa
William A. Beltran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Extensive and Prolonged Restoration of Dystrophin Expression with Vivo-Morpholino-Mediated Multiple Exon Skipping in Dystrophic Dogs
Toshifumi Yokota et al.
NUCLEIC ACID THERAPEUTICS (2012)
Dystrophin Isoform Induction In Vivo by Antisense-mediated Alternative Splicing
Sue Fletcher et al.
MOLECULAR THERAPY (2010)
Widespread Muscle Expression of an AAV9 Human Mini-dystrophin Vector After Intravenous Injection in Neonatal Dystrophin-deficient Dogs
Joe N. Kornegay et al.
MOLECULAR THERAPY (2010)
Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs
Toshifumi Yokota et al.
ANNALS OF NEUROLOGY (2009)
Gene Therapy in Large Animal Models of Muscular Dystrophy
Zejing Wang et al.
ILAR JOURNAL (2009)
Octa-guanidine Morpholino Restores Dystrophin Expression in Cardiac and Skeletal Muscles and Ameliorates Pathology in Dystrophic mdx Mice
Bo Wu et al.
MOLECULAR THERAPY (2009)
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
Natee Jearawiriyapaisarn et al.
MOLECULAR THERAPY (2008)
Systemic microdystrophin gene delivery improves skeletal muscle structure and function in old dystrophic mdx mice
Paul Gregorevic et al.
MOLECULAR THERAPY (2008)
Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression
Zejing Wang et al.
MOLECULAR THERAPY (2007)
Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy
Zejing Wang et al.
HUMAN GENE THERAPY (2007)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy
P Dowling et al.
BIOCHEMICAL JOURNAL (2004)
Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse
QL Lu et al.
NATURE MEDICINE (2003)
Prolonged dystrophin expression and functional correction of mdx mouse muscle following gene transfer with a helper-dependent (gutted) adenovirus-encoding murine dystrophin
R Gilbert et al.
HUMAN MOLECULAR GENETICS (2003)
Canine X-linked muscular dystrophy in Japan (CXMDj)
Y Shimatsu et al.
EXPERIMENTAL ANIMALS (2003)
Share Paper
